You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 6, December 1968 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Idiopathic Isosexual Precocity

Therapy With Medroxyprogesterone

Solomon A. Kaplan, MD; Shun M. Ling, MD; Nayer G. Irani, MD

Am J Dis Child. 1968;116(6):591-598.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN 1962 Kupperman and Epstein1 suggested that medroxyprogesterone acetate (MPA) may be useful in the treatment of idiopathic isosexual precocity in infants and children. This agent was selected over other hormonal inhibitors of gonadotropin secretion because it apparently had no androgenic or estrogenic potential. After treating five girls with idiopathic isosexual precocity for periods of 4 to 14 months with a long-acting preparation (Depo-Provera), they reported their preliminary observations that use of MPA had arrested menstruation, reduced the cornification of the basal cells of the vaginal epithelium, and diminished mammary growth. In two boys with the syndrome, spermatogenesis was apparently arrested and the excretion of 17-ketosteroids was diminished following treatment. The question as to whether the treatment had modified the rate of linear growth or rate of epiphyseal maturation could not be resolved by their study, which was limited in the number of patients studied and in its duration. . . . [Full Text PDF of this Article]


Author Affiliations

Los Angeles

From the Childrens Hospital of Los Angeles and the Department of Pediatrics, University of Southern California, Los Angeles. Doctor Kaplan is now with the Department of Pediatrics, UCLA Center for the Health Sciences, Los Angeles.


Footnotes

Received for publication Nov 12, 1967.

Reprint requests to Department of Pediatrics, UCLA Center for the Health Sciences, Los Angeles 90024 (Dr. Kaplan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.